DMEPOS Competitive Bidding in 2017: Reform Options and Opportunities under the Trump Administration
Many DME suppliers have argued that the current competitive bidding program has design flaws that have created unprofitable reimbursement rates, decreased patient access to durable medical equipment, and forced many suppliers to exit the market. With the new Trump Administration and the proposals made by HHS Secretary Tom Price, there may be hope for suppliers for reform options and new opportunities for the DMEPOS Competitive bidding program.
See how the new Administration may impact your business and how this affects competitive bidding in the live webinar, led by Matthew Agnew and Emily Shaw from Polsinelli Health Care Regulatory Associates.
This presentation will help you:
- Understand the current competitive bidding program’s design and reasons for criticism
- Evaluate Secretary Price’s market pricing program proposal
- Analyze potential reform options and how this impacts DME suppliers